Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Melanoma × Echocardiography × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 10 Breast Neoplasms 4 Heart Failure 3 Neoplasms 2 Heart Diseases 2 Ventricular Dysfunction, Left 1 Ventricular Dysfunction 1 Thoracic Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Obesity 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Metabolic Syndrome 1 Memory Disorders 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Dyspnea 1 Diabetes Mellitus, Type 1 1 Cognitive Dysfunction 1 Cardiovascular Diseases 1 Cardiomyopathies 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Atherosclerosis 1

Interventions

Blood Specimen Collection 12 Nivolumab 11 Ipilimumab 11 pembrolizumab 10 Surveys and Questionnaires 8 trametinib 7 Gene Expression Profiling 7 dabrafenib 6 Biopsy 5 Specimen Handling 4 Immunotherapy 4 Amplified Fragment Length Polymorphism Analysis 4 atezolizumab 3 Restraint, Physical 3 Introns 3 Immunohistochemistry 3 tremelimumab 2 aldesleukin 2 Watchful Waiting 2 Therapeutics 2 Surgical Procedures, Operative 2 Polymerase Chain Reaction 2 Methods 2 Magnetic Resonance Spectroscopy 2 Liquid Biopsy 2 Interferon-alpha 2 Histocompatibility Testing 2 Flow Cytometry 2 Drug Therapy 2 Diagnostic Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡